📑DETECCION DE MUTACION DE ENZIMA MTHFR (ESTADO TROMBOFILICO), DOSIFICACION DE FACTOR V (FACTOR DE LEIDEN) COAGULANTE
Procurement process summary
This process is to purchase Deteccion de mutacion de enzima mthfr (estado trombofilico), dosificacion de factor v (factor de leiden) coagulante.
This contract was awarded by 🇺🇾 Dirección Nacional de Sanidad de las Fuerzas Armadas for an amount of UYU 52,693 to 1 supplier. It was published on 2006-01-09 through not reported
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇺🇾 Dirección Nacional de Sanidad de las Fuerzas Armadas Buying unitnot reported Publication date2006-01-09 Contest statusnot reported DescriptionR/214417030013Awards
This award was granted to ATGEN S.R.L. by Dirección Nacional de Sanidad de las Fuerzas Armadas for an amount of UYU 52,693. The procurement process was conducted through Not available for the category of Not available. The award was granted on 2005-11-03.
| Supplier | Amount | Award date |
|---|---|---|
| 🇺🇾 ATGEN S.R.L. | UYU 52,693 | 2005-11-03 |
Market context and opportunities
The execution of this contract allows the entity Dirección Nacional de Sanidad de las Fuerzas Armadas to fulfill its public service objectives efficiently.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUY_ocds-yfs5dr-a105014-R-214417030013Publication date2006-01-09Contract datenot reportedAward date2005-11-03Categoriesnot reportedPurchase modalitynot reportedMethod detailsnot reportedStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
